Sugi Predict

Sugi Predict / Compounds / SCHEMBL4917067

SCHEMBL4917067

SCHEMBL4917067

O=c1oc2ccccc2cc1P(=O)(O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 4/20 0.58
▸ TYR P14679 1/20 0.58
▸ DAO P14920 1/20 0.58
▸ AKR1B1 P15121 1/20 0.58
▸ SMN1; SMN2 Q16637 4/20 0.53
▸ POLB P06746 1/20 0.53
▸ MAOB P27338 8/20 0.53
▸ CA12 O43570 2/20 0.53
▸ CA9 Q16790 2/20 0.53
▸ CA1 P00915 1/20 0.53
▸ CA3 P07451 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ CA4 P22748 1/20 0.53
▸ CA6 P23280 1/20 0.53
▸ CA5A P35218 1/20 0.53
▸ CA7 P43166 1/20 0.53
▸ GPR35 Q9HC97 1/20 0.53
▸ CA14 Q9ULX7 1/20 0.53
▸ CA5B Q9Y2D0 1/20 0.53
▸ KDM4E B2RXH2 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30876784 1.00 HPGD (0.58) HPGDTYRDAOAKR1B1SMN1; SMN2
SCHEMBL23041007 0.79 HSD17B3 (0.58) HPGDAKR1B1POLBCA12CA9
3-Hydroxycoumarin SCHEMBL28805372 0.79 HPGD (0.86) HPGDTYRDAOAKR1B1SMN1; SMN2
Phosphoric Acid SCHEMBL28586709 0.77 TYR (0.56) HPGDTYRDAOAKR1B1SMN1; SMN2
Phosphoric Acid SCHEMBL27693937 0.75 MAOB (0.58) HPGDTYRDAOAKR1B1SMN1; SMN2
SCHEMBL1325816 0.75 MMP2 (0.54) HPGDTYRDAOAKR1B1SMN1; SMN2
3-Hydroxycoumarin SCHEMBL76090 0.73 HPGD (1.00) HPGDTYRDAOAKR1B1SMN1; SMN2
3-Hydroxycoumarin SCHEMBL29397603 0.73 HPGD (1.00) HPGDTYRDAOAKR1B1SMN1; SMN2
3-Hydroxycoumarin SCHEMBL28145356 0.73 HPGD (0.89) HPGDTYRDAOAKR1B1SMN1; SMN2
SCHEMBL29517170 0.72 RAB9A (0.78) HPGDTYRDAOAKR1B1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105037428-B Preparation method for coumarin-3-phosphonate derivative 河南工业大学 2017-01-25 — — CN claimed
CN-105037428-A Preparation method for coumarin-3-phosphonate derivative UNIV HENAN TECHNOLOGY 2015-11-11 — — CN claimed
CN-101497632-B Method for synthesizing coumarin-3-phosphonate derivative UNIV SOOCHOW 2012-01-25 — — CN claimed
CN-101497632-A Method for synthesizing coumarin-3-phosphonate derivative UNIV SOOCHOW (CN) 2009-08-05 — — CN claimed
US-10864222-B1 Beta-lactamase inhibitors, formulations, and uses thereof UNIVERSITY OF SOUTH FLORIDA (US) 2020-12-15 — — US disclosed
US-10543221-B2 Beta-lactamase inhibitors, formulations, and uses thereof UNIVERSITY OF SOUTH FLORIDA (US) 2020-01-28 — — US disclosed
US-20180360857-A1 BETA-LACTAMASE INHIBITORS, FORMULATIONS, AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-12-20 — — US disclosed
WO-2017156458-A1 BETA-LACTAMASE INHIBITORS, FORMULATIONS, AND USES THEREOF UNIVERSITY OF SOUTH FLORIDA (US) 2017-09-14 — — WO disclosed
CN-105037428-B Preparation method for coumarin-3-phosphonate derivative 河南工业大学 2017-01-25 — — CN disclosed
CN-105037428-B Preparation method for coumarin-3-phosphonate derivative 河南工业大学 2017-01-25 — — CN disclosed
CN-105037428-B Preparation method for coumarin-3-phosphonate derivative 河南工业大学 2017-01-25 — — CN disclosed
CN-105037428-A Preparation method for coumarin-3-phosphonate derivative UNIV HENAN TECHNOLOGY 2015-11-11 — — CN disclosed
CN-101497632-B Method for synthesizing coumarin-3-phosphonate derivative UNIV SOOCHOW 2012-01-25 — — CN disclosed
CN-101497632-A Method for synthesizing coumarin-3-phosphonate derivative UNIV SOOCHOW (CN) 2009-08-05 — — CN disclosed
CN-101497632-A Method for synthesizing coumarin-3-phosphonate derivative UNIV SOOCHOW (CN) 2009-08-05 — — CN disclosed
CN-101497632-A Method for synthesizing coumarin-3-phosphonate derivative UNIV SOOCHOW (CN) 2009-08-05 — — CN disclosed
US-20080076738-A1 Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds GILEAD SCIENCES, INC. 2008-03-27 — — US disclosed
EP-1742642-A2 PHOSPHONATE ANALOGS OF HIV INTEGRASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2007-01-17 — — EP disclosed
US-20060116356-A1 Phosphonate analogs of HIV integrase inhibitor compounds GILEAD SCIENCES, INC. 2006-06-01 — — US disclosed
WO-2005117904-A2 PHOSPHONATE ANALOGS OF HIV INTEGRASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2005-12-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180360857-A1 BETA-LACTAMASE INHIBITORS, FORMULATIONS, AND USES THEREOF PEPD, LCT, MGAM HPGD 168/4885TYR 1999/4885DAO 179/4885
US-20060116356-A1 Phosphonate analogs of HIV integrase inhibitor compounds TYMP, PNP, PIKFYVE HPGD 1374/4885TYR 4792/4885DAO 1886/4885
US-10864222-B1 Beta-lactamase inhibitors, formulations, and uses thereof PEPD, LCT, MGAM HPGD 168/4885TYR 1999/4885DAO 179/4885
US-20080076738-A1 Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds TYMP, PNP, PIKFYVE HPGD 1374/4885TYR 4792/4885DAO 1886/4885
US-10543221-B2 Beta-lactamase inhibitors, formulations, and uses thereof PEPD, LCT, MGAM HPGD 168/4885TYR 1999/4885DAO 179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.